Rahul Banerjee, MD, FACP(@RahulBanerjeeMD) 's Twitter Profileg
Rahul Banerjee, MD, FACP

@RahulBanerjeeMD

Asst Professor @UWMedicine @fredhutch. Goals: improve pt experience in myeloma #MMsm: ⬇️ dex, ⬆️ time at home, 📱-based wellness.

COI: https://t.co/3Uuojuio6R

ID:26399236

linkhttps://www.ncbi.nlm.nih.gov/myncbi/rahul.banerjee.2/bibliography/public/ calendar_today25-03-2009 02:04:42

22,7K Tweets

8,6K Followers

4,0K Following

Rahul Banerjee, MD, FACP(@RahulBanerjeeMD) 's Twitter Profile Photo

From an email sent by a CRO today…

I hope for a future* where 24-hour urine assessments don’t hold this “critical” of a role in myeloma trials 😉

* More on this topic coming soon!

From an email sent by a CRO today… I hope for a future* where 24-hour urine assessments don’t hold this “critical” of a role in myeloma #MMsm trials 😉 * More on this topic coming soon!
account_circle
Marc S. Raab(@RaabMarc) 's Twitter Profile Photo

Visiting dear friends and collaborators on my Canada educational tour de force on management of bispecific T cell enhancers on with events
at Regina, Saskatoon, Calgary, Vancouver
nizar jacques bahlis Holly Lee Paola Neri

Visiting dear friends and collaborators on my Canada educational tour de force on management of bispecific T cell enhancers on #mmsm with events at Regina, Saskatoon, Calgary, Vancouver @NBahlis @hollyleeYJ Paola Neri
account_circle
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰(@szusmani) 's Twitter Profile Photo

Thank you for the invite and great discussion about how to operationalize outpt BsAbs, our UK colleagues are very well positioned to implement it!

account_circle
Multiple Myeloma RF(@theMMRF) 's Twitter Profile Photo

SAVE THE DATE 💌 On 5/13, Dr. Craig Cole and Amy Blake, NP-C from Karmanos Cancer Institute will discuss the lab tests and reports requested for multiple patients. Don’t miss out—register today: ow.ly/vgCi50Rpopr

SAVE THE DATE 💌 On 5/13, Dr. @CraigEmmittCole and Amy Blake, NP-C from @karmanoscancer will discuss the lab tests and reports requested for multiple #myeloma patients. Don’t miss out—register today: ow.ly/vgCi50Rpopr #mmsm
account_circle
Luciano J Costa(@End_myeloma) 's Twitter Profile Photo

pulse check. Patient seen last week for discussion of ASCT, 74 yo, standard risk disease, D-VRd x 6-> sCR with MRD = 1 x 10-6. No relevant comorbidities. What would you recommend?

account_circle
Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo

Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients [Nov 25, 2021] Mariano Arribas et al. Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 AmericanJournalofHematology onlinelibrary.wiley.com/doi/full/10.10… HT Rahul Banerjee, MD, FACP

Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients [Nov 25, 2021] Mariano Arribas et al. @Rfonsi1 @AjHematology onlinelibrary.wiley.com/doi/full/10.10… #mmsm #bmtsm #IDonc HT @RahulBanerjeeMD
account_circle
Journal for ImmunoTherapy of Cancer(@jitcancer) 's Twitter Profile Photo

New article: Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T bit.ly/3JIfoxa Kaska

New #JITC article: Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T bit.ly/3JIfoxa @KaskaK21
account_circle